Grifols, SA (ES:GRF.P)
BME:GRF.P
Holding ES:GRF.P?
Track your performance easily

Grifols (GRF.P) Stock Price & Analysis

4 Followers

GRF.P Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

5.80%0.02%92.42%
Insiders
0.02% Other Institutional Investors
92.42% Public Companies and
Individual Investors

GRF.P FAQ

What was Grifols, SA’s price range in the past 12 months?
Grifols, SA lowest stock price was €4.84 and its highest was €10.98 in the past 12 months.
    What is Grifols, SA’s market cap?
    Currently, no data Available
    When is Grifols, SA’s upcoming earnings report date?
    Grifols, SA’s upcoming earnings report date is Feb 27, 2025 which is in 105 days.
      How were Grifols, SA’s earnings last quarter?
      Grifols, SA released its earnings results on Nov 07, 2024. The company reported €0.076 earnings per share for the quarter, missing the consensus estimate of €0.199 by -€0.123.
        Is Grifols, SA overvalued?
        According to Wall Street analysts Grifols, SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Grifols, SA pay dividends?
          Grifols, SA pays a Annually dividend of <€0.01 which represents an annual dividend yield of N/A. See more information on Grifols, SA dividends here
            What is Grifols, SA’s EPS estimate?
            Grifols, SA’s EPS estimate is €0.19.
              How many shares outstanding does Grifols, SA have?
              Grifols, SA has 261,425,100 shares outstanding.
                What happened to Grifols, SA’s price movement after its last earnings report?
                Grifols, SA reported an EPS of €0.076 in its last earnings report, missing expectations of €0.199. Following the earnings report the stock price went up 1.071%.
                  Which hedge fund is a major shareholder of Grifols, SA?
                  Currently, no hedge funds are holding shares in ES:GRF.P
                  ---

                  Grifols Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  2.80%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  Trailing 12-Months
                  Asset Growth
                  -8.07%
                  Trailing 12-Months

                  Company Description

                  Grifols, SA

                  As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 78% of sales in 2019. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 14% of revenue following the Novartis and Hologic deals.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Grifols
                  GN Store Nord
                  AstraZeneca
                  Hikma Pharmaceuticals
                  Genedrive
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis